Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease (Q58571293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

1 May 2020

main subject

0 references

1 reference

Seth A Bennett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Royena Tanaz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Samantha N Cobos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Mariana P Torrente

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

language of work or name

English

0 references

publication date

12 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

19-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

Burden of rare variants in ALS genes influences survival in familial and sporadic ALS.

1 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A comprehensive review of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

FTD and ALS: a tale of two diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

ALS and FTD: an epigenetic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The epidemiology of ALS: a conspiracy of genes, environment and time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Onset and progression in inherited ALS determined by motor neurons and microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The molecular hallmarks of epigenetic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

DNA methylation patterns and epigenetic memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

DNA methylation, a hand behind neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

How do microRNAs regulate gene expression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Crystal structure of the nucleosome core particle at 2.8 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Basic concepts of epigenetics: impact of environmental signals on gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A positive role for histone acetylation in transcription factor access to nucleosomal DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone acetylation reduces nucleosome core particle linking number change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Characterization of histones and their post-translational modifications by mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The language of covalent histone modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Cross-regulation of histone modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Epigenetic regulation of motor neuron cell death through DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Genome-scale DNA methylation maps of pluripotent and differentiated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

miRNAs: their discovery, biogenesis and mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Slicer and the argonautes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Principles of microRNA-target recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Perspective: machines for RNAi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Control of translation and mRNA degradation by miRNAs and siRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Alzheimer's disease: presence and role of microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

MicroRNAs in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Reelin and brain development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Argonaute proteins regulate microRNA stability: Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Glutamate receptors: RNA editing and death of motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone deacetylases (HDACs): characterization of the classical HDAC family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Targeting histone deacetylases for the treatment of cancer and inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

New and emerging HDAC inhibitors for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone H3 phosphorylation - a versatile chromatin modification for different occasions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Crystal structure and functional analysis of the histone methyltransferase SET7/9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Writing, erasing and reading histone lysine methylations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Elongator is a histone H3 and H4 acetyltransferase important for normal histone acetylation levels in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Gcn5- and Elp3-induced histone H3 acetylation regulates hsp70 gene transcription in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

HSP104 required for induced thermotolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone H3 lysine 14 (H3K14) acetylation facilitates DNA repair in a positioned nucleosome by stabilizing the binding of the chromatin Remodeler RSC (Remodels Structure of Chromatin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone H3 lysine 14 acetylation is required for activation of a DNA damage checkpoint in fission yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Combinatorial patterns of histone acetylations and methylations in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Dynamics of nucleosome remodelling by individual ACF complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone deacetylases and their role in motor neuron degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Subcellular Distribution of HDAC1 in Neurotoxic Conditions Is Dependent on Serine Phosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A novel action of histone deacetylase inhibitors in a protein aggresome disease model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Phase 2 study of sodium phenylbutyrate in ALS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

An epigenetic road map for histone lysine methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

The predominant protein-arginine methyltransferase from Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Epigenetic Changes in Neurodegenerative Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

A loss of FUS/TLS function leads to impaired cellular proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Novel functional residues in the core domain of histone H2B regulate yeast gene expression and silencing and affect the response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Snf1--a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

C9orf72 expansion disrupts ATM-mediated chromosomal break repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Autophagy Regulates Chromatin Ubiquitination in DNA Damage Response through Elimination of SQSTM1/p62.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

DNA damage sensing by the ATM and ATR kinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone modification: cause or cog?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Protein phosphatase 2A activity affects histone H3 phosphorylation and transcription in Drosophila melanogaster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Chromatin-associated Protein Phosphatase 1 Regulates Aurora-B and Histone H3 Phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

JMJD6 is a histone arginine demethylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Chromatin modifications and their function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone acetylation in chromatin structure and transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Histone H4-K16 acetylation controls chromatin structure and protein interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Cancer genetics and epigenetics: two sides of the same coin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Predicting nucleosome positions on the DNA: combining intrinsic sequence preferences and remodeler activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Conformational dynamics of the chromatin fiber in solution: determinants, mechanisms, and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Senataxin mutations and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2018.10.002

Nucleosome linking number change controlled by acetylation of histones H3 and H4.

7 January 2021

1 reference

12 December 2020

Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA.

1 reference

12 December 2020

Gamma-H2AX - a novel biomarker for DNA double-strand breaks.

1 reference

12 December 2020

Edaravone in the treatment of amyotrophic lateral sclerosis: efficacy and access to therapy - a roundtable discussion

1 reference

12 December 2020

10.1016/J.TRSL.2018.10.002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30391475%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference